RAR-related orphan receptor gamma explained

RAR-related orphan receptor gamma (RORγ) is a protein that in humans is encoded by the (RAR-related orphan receptor C) gene.[1] RORγ is a member of the nuclear receptor family of transcription factors. It is mainly expressed in immune cells (Th17 cells) and it also regulates circadian rhythms. It may be involved in the progression of certain types of cancer.

Gene expression

Two isoforms are produced from the same RORC gene,[2] probably by selection of alternative promoters.[3]

RORγ

The mRNA of the first isoform, RORγ is expressed in many tissues, including thymus, lung, liver, kidney, muscle, and brown fat.[1] [6] [7] While RORγ mRNA is abundantly expressed, attempts to detect RORγ protein have not been successful; therefore it is not clear whether RORγ protein is actually expressed.[8] Consistent with this, the main phenotypes identified in RORγ-/- knockout mice (where neither isoform is expressed) are those associated with RORγt immune system function and an isoform specific RORγt knockout displayed a phenotype identical to the RORγ-/- knockout. On the other hand, circadian phenotypes of RORγ-/- mice[9] in tissues where the RORγt isoform is expressed in minute amounts argues for the expression of functional RORγ isoform. Absent protein in previous studies may be due to the high amplitude circadian rhythm of expression of this isoform in some tissues.

The mRNA is expressed in various peripheral tissues, either in a circadian fashion (e.g., in the liver and kidney) or constitutively (e.g., in the muscle).[10] [11]

In contrast to other ROR genes, the RORC gene is not expressed in the central nervous system.

RORγt

The second isoform, RORγt, is expressed in various immune cells. Of those, the most prominent examples are immature CD4+/CD8+ thymocytes, T helper 17 (Th17) cells and in type 3 innate lymphoid cells (ILC3). Mice lacking RORγt are devoid of lymph nodes and Peyer's patches due to the lack of Lymphoid tissue inducer cells (LTi), a subpopulation of ILC3s and important drivers of lymphoid organogenesis. [12] [13] [14] [15] RORγt inhibitors are under development for the treatment of autoimmune diseases such as psoriasis and rheumatoid arthritis.[8] [16]

Function

The RORγ protein is a DNA-binding transcription factor and is a member of the NR1 subfamily of nuclear receptors.[17] Although the specific functions of this nuclear receptor have not been fully characterized yet, some roles emerge from the literature on the mouse gene.

Circadian rhythms

The RORγ isoform appears to be involved in the regulation of circadian rhythms. This protein can bind to and activate the promoter of the ARNTL (BMAL1) gene,[18] a transcription factor central to the generation of physiological circadian rhythms. Also, since the levels of RORγ are rhythmic in some tissues (liver, kidney), it has been proposed to impose a circadian pattern of expression on a number of clock-controlled genes, for example the cell cycle regulator p21.[19] Conversely, it has also been demonstrated that RORγt+ enteric ILC3s themselves are under circadian control, being entrained by light that is sensed by the suprachiasmatic nucleus. Importantly, the deletion of ARNTL in ILC3s using a RORc promoter disrupted enteric defence, reinforcing the role of clock machinery in the control of RORγt. Whilst ILC3s themselves oscillate in a circadian manner and exhibit diurnal variations in the expression of clock genes, it remains unclear exactly how the central clock relays these signals to the RORγt+ ILC3s in the gut.[20] [21] [22]

Immune regulation

RORγt is the most studied of the two isoforms. Its best understood functionality is in the immune system. The transcription factor is essential for lymphoid organogenesis in the embryo, in particular lymph nodes and Peyer's patches, but not the spleen.[13] [23] It is essential for the specific immune cells responsible for embryonic lymphoid formation, the Lymphoid Tissue inducer (LTi) cells. Within these cells, retinoic acid induces expression of RORc. Consequently, removing the metabolic ground product for retinoic acid, vitamin A, from the diet of pregnant mice resulted in lower embryonic LTi cell differentiation, leading to smaller lymph nodes in the adult offspring and finally resulting in lower capabilities to clear a virus.[24] RORγt also plays an important regulatory role in thymopoiesis, by reducing apoptosis of thymocytes and promoting thymocyte differentiation into pro-inflammatory T helper 17 (Th17) cells.[13] [23] [25] It also plays a role in inhibiting apoptosis of undifferentiated T cells and promoting their differentiation into Th17 cells, possibly by down regulating the expression of Fas ligand and IL2, respectively .[2]

Despite the pro-inflammatory role of RORγt in the thymus, it is expressed in a Treg cell subpopulation in the colon, and is induced by symbiotic microflora. Abrogation of the gene's activity generally increases type 2 cytokines and may make mice more vulnerable to oxazolone-induced colitis.[26]

Cancer

RORγ is expressed in certain subsets of cancer stem cells (EpCAM+/MSI2+) in pancreatic cancer and shows a strong correlation with tumor stage and lymph node invasion.[27] Amplification of the RORC gene has also been observed in other malignancies such as lung, breast and neuroendocrine prostate cancer.

Ligands

Intermediates within the cholesterol pathway have been shown to activate RORγt.[28] Various oxysterols are claimed to be an activator of RORγ, but with lower potency as cholesterol intermediates.[29]

As a drug target

As antagonism of the RORγ receptor may have therapeutic applications in the treatment of inflammatory diseases, a number of synthetic RORγ receptor antagonists have been developed.[30]

Agonists may allow the immune system to combat cancer. LYC-55716 is an oral, selective RORγ (RORgamma) agonist in clinical trials on patients with solid tumors.[31]

See also

Notes and References

  1. Hirose T, Smith RJ, Jetten AM . ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle . Biochemical and Biophysical Research Communications . 205 . 3 . 1976–1983 . December 1994 . 7811290 . 10.1006/bbrc.1994.2902 .
  2. He YW, Deftos ML, Ojala EW, Bevan MJ . RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells . Immunity . 9 . 6 . 797–806 . December 1998 . 9881970 . 2776668 . 10.1016/S1074-7613(00)80645-7 .
  3. Eberl G, Littman DR . The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches . Immunological Reviews . 195 . 81–90 . October 2003 . 12969312 . 10.1034/j.1600-065X.2003.00074.x . 18769627 . free .
  4. Medvedev A, Chistokhina A, Hirose T, Jetten AM . Genomic structure and chromosomal mapping of the nuclear orphan receptor ROR gamma (RORC) gene . Genomics . 46 . 1 . 93–102 . November 1997 . 9403063 . 10.1006/geno.1997.4980 .
  5. Villey I, de Chasseval R, de Villartay JP . RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter . European Journal of Immunology . 29 . 12 . 4072–4080 . December 1999 . 10602018 . 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E . free .
  6. Medvedev A, Yan ZH, Hirose T, Giguère V, Jetten AM . Cloning of a cDNA encoding the murine orphan receptor RZR/ROR gamma and characterization of its response element . Gene . 181 . 1–2 . 199–206 . November 1996 . 8973331 . 10.1016/S0378-1119(96)00504-5 . 45306810 .
  7. Ortiz MA, Piedrafita FJ, Pfahl M, Maki R . TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals . Molecular Endocrinology . 9 . 12 . 1679–1691 . December 1995 . 8614404 . 10.1210/mend.9.12.8614404 . free .
  8. Huang Z, Xie H, Wang R, Sun Z . Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity . Expert Opinion on Therapeutic Targets . 11 . 6 . 737–743 . June 2007 . 17504012 . 10.1517/14728222.11.6.737 . 42933457 .
  9. Liu AC, Tran HG, Zhang EE, Priest AA, Welsh DK, Kay SA . Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms . PLOS Genetics . 4 . 2 . e1000023 . February 2008 . 18454201 . 2265523 . 10.1371/journal.pgen.1000023 . Takahashi JS . free .
  10. Guillaumond F, Dardente H, Giguère V, Cermakian N . Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors . Journal of Biological Rhythms . 20 . 5 . 391–403 . October 2005 . 16267379 . 10.1177/0748730405277232 . 33279857 . free .
  11. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U . The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator . Cell . 110 . 2 . 251–260 . July 2002 . 12150932 . 10.1016/S0092-8674(02)00825-5 . 15224136 . free .
  12. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR . An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells . Nature Immunology . 5 . 1 . 64–73 . January 2004 . 14691482 . 10.1038/ni1022 . 24160834 .
  13. Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, Mebius RE, Littman DR . 6 . Requirement for RORgamma in thymocyte survival and lymphoid organ development . Science . 288 . 5475 . 2369–2373 . June 2000 . 10875923 . 10.1126/science.288.5475.2369 . 2000Sci...288.2369S .
  14. Eberl G, Littman DR . Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells . Science . 305 . 5681 . 248–251 . July 2004 . 15247480 . 10.1126/science.1096472 . 85035657 . 2004Sci...305..248E .
  15. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G . 6 . Lineage relationship analysis of RORgammat+ innate lymphoid cells . Science . 330 . 6004 . 665–669 . October 2010 . 20929731 . 10.1126/science.1194597 . 206528599 . 2010Sci...330..665S .
  16. News: Merck and Lycera to Develop Oral Autoimmune Disease Drugs Targeting Th17 Cells . Mar 2011 .
  17. Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, Tsai MJ, Laudet V . 6 . International Union of Pharmacology. LXVI. Orphan nuclear receptors . Pharmacological Reviews . 58 . 4 . 798–836 . December 2006 . 17132856 . 10.1124/pr.58.4.10 . Ming-Jer Tsai . 2619263 . Holly Ingraham .
  18. Akashi M, Takumi T . The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1 . Nature Structural & Molecular Biology . 12 . 5 . 441–448 . May 2005 . 15821743 . 10.1038/nsmb925 . 20040952 .
  19. Gréchez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F . The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation . The Journal of Biological Chemistry . 283 . 8 . 4535–4542 . February 2008 . 18086663 . 10.1074/jbc.M705576200 . free .
  20. Godinho-Silva C, Domingues RG, Rendas M, Raposo B, Ribeiro H, da Silva JA, Vieira A, Costa RM, Barbosa-Morais NL, Carvalho T, Veiga-Fernandes H . 6 . Light-entrained and brain-tuned circadian circuits regulate ILC3s and gut homeostasis . Nature . 574 . 7777 . 254–258 . October 2019 . 31534216 . 6788927 . 10.1038/s41586-019-1579-3 . 2019Natur.574..254G .
  21. Teng F, Goc J, Zhou L, Chu C, Shah MA, Eberl G, Sonnenberg GF . A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut . Science Immunology . 4 . 40 . eaax1215 . October 2019 . 31586011 . 7008004 . 10.1126/sciimmunol.aax1215 .
  22. Wang Q, Robinette ML, Billon C, Collins PL, Bando JK, Fachi JL, Sécca C, Porter SI, Saini A, Gilfillan S, Solt LA, Musiek ES, Oltz EM, Burris TP, Colonna M . 6 . Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells . Science Immunology . 4 . 40 . eaay7501 . October 2019 . 31586012 . 6911370 . 10.1126/sciimmunol.aay7501 .
  23. Kurebayashi S, Ueda E, Sakaue M, Patel DD, Medvedev A, Zhang F, Jetten AM . Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis . Proceedings of the National Academy of Sciences of the United States of America . 97 . 18 . 10132–10137 . August 2000 . 10963675 . 27750 . 10.1073/pnas.97.18.10132 . free . 2000PNAS...9710132K .
  24. van de Pavert SA, Ferreira M, Domingues RG, Ribeiro H, Molenaar R, Moreira-Santos L, Almeida FF, Ibiza S, Barbosa I, Goverse G, Labão-Almeida C, Godinho-Silva C, Konijn T, Schooneman D, O'Toole T, Mizee MR, Habani Y, Haak E, Santori FR, Littman DR, Schulte-Merker S, Dzierzak E, Simas JP, Mebius RE, Veiga-Fernandes H . 6 . Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity . Nature . 508 . 7494 . 123–127 . April 2014 . 24670648 . 4932833 . 10.1038/nature13158 . 2014Natur.508..123V .
  25. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR . 6 . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells . Cell . 126 . 6 . 1121–1133 . September 2006 . 16990136 . 10.1016/j.cell.2006.07.035 . 9034013 . free .
  26. Hegazy AN, Powrie F . MICROBIOME. Microbiota RORgulates intestinal suppressor T cells . Science . 349 . 6251 . 929–930 . August 2015 . 26315421 . 10.1126/science.aad0865 . 34308646 .
  27. Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T . 6 . A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma . Cell . 177 . 3 . 572–586.e22 . April 2019 . 30955884 . 6711371 . 10.1016/j.cell.2019.03.010 .
  28. Santori FR, Huang P, van de Pavert SA, Douglass EF, Leaver DJ, Haubrich BA, Keber R, Lorbek G, Konijn T, Rosales BN, Rozman D, Horvat S, Rahier A, Mebius RE, Rastinejad F, Nes WD, Littman DR . 6 . Identification of natural RORγ ligands that regulate the development of lymphoid cells . Cell Metabolism . 21 . 2 . 286–298 . February 2015 . 25651181 . 4317570 . 10.1016/j.cmet.2015.01.004 .
  29. Hu X, Wang Y, Hao LY, Liu X, Lesch CA, Sanchez BM, Wendling JM, Morgan RW, Aicher TD, Carter LL, Toogood PL, Glick GD . 6 . Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists . Nature Chemical Biology . 11 . 2 . 141–147 . February 2015 . 25558972 . 10.1038/nchembio.1714 .
  30. Fauber BP, Magnuson S . Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc) . Journal of Medicinal Chemistry . 57 . 14 . 5871–5892 . July 2014 . 24502334 . 10.1021/jm401901d .
  31. Web site: Lycera Announces Initiation of Phase 1b Study of Novel Immuno-Oncology Candidate LYC-55716 in Combination with Pembrolizumab . January 2018 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "RAR-related orphan receptor gamma".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.